Yanyu Wang

Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells

Daniel A. Lichtenstein, Fiorella Schischlik, Lipei Shao et al. · Blood · 2021 · 173 citations · Full text

Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma

Nan Zhang, Yang Xu, Mingjian Piao et al. · Biomarker Research · 2024 · 72 citations · Full text

The Efficacy and Safety of Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer: A Prospective Clinical Study

Dongxu Wang, Xu Yang, Junyu Long et al. · Frontiers in Oncology · 2021 · 52 citations · Full text

Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib

Yudong Su, Xiang Long, Yang Song et al. · Targeted Oncology · 2019 · 42 citations

Health Sciences, Medicine, Pathology +11

Comparison of Baseline⁶⁸Ga-FAPI and¹⁸F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib

Meiqi Wu, Yanyu Wang, Qiao Yang et al. · Journal of Nuclear Medicine · 2023 · 42 citations · Full text